|
US3709898A
(en)
|
1971-02-09 |
1973-01-09 |
Upjohn Co |
Process for the production of triazolobenzodiazepines and intermediates
|
|
US3681343A
(en)
|
1971-05-11 |
1972-08-01 |
Upjohn Co |
6-phenyl-s-triazolo{8 4,3-a{9 {8 1,4{9 {0 benzodiazepines
|
|
US3812259A
(en)
|
1971-08-09 |
1974-05-21 |
Upjohn Co |
Animal feed and process
|
|
CH622019A5
(en)
|
1975-10-23 |
1981-03-13 |
Upjohn Co |
Process for the preparation of aminotriazolobenzodiazepines
|
|
FR2329668A1
(fr)
|
1975-10-27 |
1977-05-27 |
Upjohn Co |
Procede de preparation d'aminotriazolobenzodiazepines
|
|
EP0087850A1
(en)
|
1982-01-04 |
1983-09-07 |
The Upjohn Company |
Benzodiazepines for anti-hypertensive use
|
|
DE3435973A1
(de)
|
1984-10-01 |
1986-04-10 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
|
|
JPS62181282A
(ja)
|
1986-01-21 |
1987-08-08 |
ベ−リンガ− インゲルハイム コマンデイツト ゲゼルシヤフト |
チエノ−１，４−ジアゼピン
|
|
DE3724164A1
(de)
|
1986-07-25 |
1988-01-28 |
Boehringer Ingelheim Kg |
Neue 1,4-benzodiazepine, ihre herstellung und verwendung
|
|
EP0315698B1
(en)
|
1987-05-28 |
1993-03-03 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thieno(triazolo)diazepine compounds and medicinal application of the same
|
|
JPH0676326B2
(ja)
|
1988-05-24 |
1994-09-28 |
吉富製薬株式会社 |
循環器系疾患治療薬
|
|
EP0368175A1
(de)
*
|
1988-11-06 |
1990-05-16 |
Boehringer Ingelheim Kg |
3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
|
|
EP0387613A1
(de)
|
1989-03-03 |
1990-09-19 |
Boehringer Ingelheim Kg |
Neue Thienodiazepine
|
|
EP0407955A1
(de)
|
1989-07-12 |
1991-01-16 |
Boehringer Ingelheim Kg |
Neue Hetrazepine mit PAF-antagonistischer Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE4010528A1
(de)
|
1990-04-02 |
1991-10-17 |
Boehringer Ingelheim Kg |
Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
|
|
JP2959591B2
(ja)
|
1990-05-23 |
1999-10-06 |
吉富製薬株式会社 |
チエノトリアゾロジアゼピン化合物
|
|
DE4107521A1
(de)
|
1991-03-08 |
1992-09-10 |
Boehringer Ingelheim Kg |
Neue acylaminosubstituierte hetrazepine
|
|
US5593988A
(en)
|
1991-10-11 |
1997-01-14 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Therapeutic agent for osteoporosis and diazepine compound
|
|
EP0661284A1
(en)
*
|
1992-09-18 |
1995-07-05 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienodiazepine compound and medicinal use thereof
|
|
WO1994022872A1
(fr)
|
1993-03-30 |
1994-10-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Inhibiteur d'adhesion cellulaire et compose a base de thienotriazolodiazepine
|
|
JP3001979U
(ja)
|
1994-03-14 |
1994-09-06 |
有限会社マルセ木工 |
竿掛け具
|
|
WO1995032963A1
(en)
*
|
1994-06-01 |
1995-12-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienylazole compound and thienotriazolodiazepine compound
|
|
AU4296196A
(en)
|
1995-01-06 |
1996-07-24 |
F. Hoffmann-La Roche Ag |
Hydroxymethylimidazodiazepines and their esters
|
|
ATE230600T1
(de)
|
1995-09-09 |
2003-01-15 |
Hoffmann La Roche |
Verwendung eines thienotriazoldiazepins zur erhöhung des apolopoproteins a-i niveaus
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
CN1227555A
(zh)
|
1996-06-12 |
1999-09-01 |
日本烟草产业株式会社 |
细胞因子生成抑制剂、三氮䓬化合物及其中间体
|
|
US5693641A
(en)
|
1996-08-16 |
1997-12-02 |
Berlex Laboratories Inc. |
Bicyclic pyrimidine derivatives and their use as anti-coagulants
|
|
PT989131E
(pt)
|
1996-09-13 |
2003-03-31 |
Mitsubishi Pharma Corp |
Compostos de trienotriazolodiazepina e suas utilizacoes com fins medicinais
|
|
US6444664B1
(en)
|
1997-04-18 |
2002-09-03 |
Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) |
Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
JPH11228576A
(ja)
|
1997-12-10 |
1999-08-24 |
Japan Tobacco Inc |
アポトーシス抑制剤
|
|
FR2779652B1
(fr)
|
1998-06-15 |
2001-06-08 |
Sod Conseils Rech Applic |
Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
|
|
US7589167B2
(en)
|
2000-02-22 |
2009-09-15 |
J. David Gladstone Institutes |
ZA loops of bromodomains
|
|
CA2412776C
(en)
|
2000-06-16 |
2011-03-15 |
Mitsubishi Pharma Corporation |
Compositions controlling release ph range and/or speed
|
|
AU2001270297A1
(en)
|
2000-06-30 |
2002-01-14 |
Neurogen Corporation |
2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands
|
|
US20060142257A1
(en)
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
|
US6979682B2
(en)
|
2001-02-23 |
2005-12-27 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
|
|
EP1427730B1
(de)
|
2001-09-04 |
2006-07-12 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
|
US6806272B2
(en)
|
2001-09-04 |
2004-10-19 |
Boehringer Ingelheim Pharma Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
US20030216758A1
(en)
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
JP3096299U
(ja)
|
2003-02-20 |
2003-09-12 |
宇輪工業股▲ふん▼有限公司 |
足踏み式健康器
|
|
UA80743C2
(en)
|
2003-02-26 |
2007-10-25 |
Boehringer Ingelheim Pharma |
Dihydropteridinones, method for the production and use thereof in the form of drugs
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
WO2005002526A2
(en)
|
2003-07-01 |
2005-01-13 |
President And Fellows Of Harvard College |
Method and compositions for treatment of viral infections
|
|
JP2007505858A
(ja)
|
2003-09-18 |
2007-03-15 |
ノバルティス アクチエンゲゼルシャフト |
増殖性障害の処置に有用な２，４−ジ（フェニルアミノ）ピリミジン
|
|
EP1528056A1
(en)
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
US20060035903A1
(en)
|
2004-08-14 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Storage stable perfusion solution for dihydropteridinones
|
|
US7728134B2
(en)
|
2004-08-14 |
2010-06-01 |
Boehringer Ingelheim International Gmbh |
Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
|
|
US7759485B2
(en)
|
2004-08-14 |
2010-07-20 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of dihydropteridinones
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
JP2008510771A
(ja)
|
2004-08-27 |
2008-04-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ジヒドロプテリジノン、その製造方法および医薬薬剤としてのその使用
|
|
GB0419161D0
(en)
|
2004-08-27 |
2004-09-29 |
Novartis Ag |
Organic compounds
|
|
CN1759834B
(zh)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
|
|
EP1887008B1
(en)
|
2005-05-30 |
2021-04-21 |
Mitsubishi Tanabe Pharma Corporation |
Thienotriazolodiazepine compound and a medicinal use thereof
|
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
AU2006254840B2
(en)
|
2005-06-08 |
2012-08-02 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
|
JP2009503014A
(ja)
|
2005-08-03 |
2009-01-29 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器系疾患の治療におけるジヒドロプテリジノン
|
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
NZ567851A
(en)
|
2005-11-01 |
2011-09-30 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
MX2008008320A
(es)
|
2005-12-23 |
2008-09-03 |
Smithkline Beecham Corp |
Inhibidores de azaindol de aurora cinasas.
|
|
AU2007207053B2
(en)
|
2006-01-17 |
2012-05-24 |
F. Hoffmann-La Roche Ag |
Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of Alzheimer's disease via GABA receptors
|
|
CA2652648C
(en)
|
2006-02-14 |
2016-10-25 |
Vertex Pharmaceuticals Incorporated |
Dihydrodiazepines useful as inhibitors of protein kinases
|
|
ZA200806871B
(en)
|
2006-02-14 |
2009-10-28 |
Vertex Pharma |
Dihydrodiazepines useful as inhibitors of protein kinases
|
|
US20070218135A1
(en)
|
2006-03-14 |
2007-09-20 |
Glenmark Pharmaceuticals Limited |
Sustained release matrix pharmaceutical composition
|
|
MX2008014008A
(es)
|
2006-05-03 |
2009-03-25 |
Novartis Ag |
Uso de compuestos organicos.
|
|
EP2029599A1
(en)
|
2006-05-19 |
2009-03-04 |
Astra Zeneca AB |
Dihydropteridine compounds as anti proliferative agents
|
|
WO2008009909A1
(en)
|
2006-07-17 |
2008-01-24 |
Astrazeneca Ab |
Pteridimones as modulators of polo-like kinase
|
|
NZ576278A
(en)
|
2006-10-19 |
2011-12-22 |
Signal Pharm Llc |
Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors
|
|
US8338464B2
(en)
|
2006-11-30 |
2012-12-25 |
Albert Einstein College Of Medicine Of Yeshiva University |
Small molecule inhibitors of BCL6
|
|
JP2008156311A
(ja)
|
2006-12-26 |
2008-07-10 |
Institute Of Physical & Chemical Research |
Ｂｒｄ２ブロモドメイン結合剤
|
|
ES2804801T3
(es)
|
2006-12-26 |
2021-02-09 |
Lantheus Medical Imaging Inc |
Ligandos para la formación de imágenes de la inervación cardíaca
|
|
CN102746175B
(zh)
|
2007-03-22 |
2014-01-15 |
武田药品工业株式会社 |
可用作plk1抑制剂的取代的嘧啶并二氮杂*
|
|
WO2008137081A1
(en)
|
2007-05-02 |
2008-11-13 |
The Trustees Of Columbia University In The City Of New York |
Substituted ( 5, 6 ) -dihydronaphraalenyl compounds as reversible male contraceptives
|
|
KR20080107050A
(ko)
|
2007-06-05 |
2008-12-10 |
울산대학교 산학협력단 |
항-ｃｄ１３７ 단일클론 항체를 포함하는 만성이식편대숙주 질환의 예방 또는 치료용 약학적 조성물
|
|
US8461149B2
(en)
|
2007-08-15 |
2013-06-11 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as protein kinase inhibitors
|
|
CN103122001A
(zh)
|
2007-09-25 |
2013-05-29 |
武田药品工业株式会社 |
Polo样激酶抑制剂
|
|
EP2610256B1
(en)
|
2007-09-28 |
2016-04-27 |
Cyclacel Limited |
Pyrimidine derivatives as protein kinase inhibitors
|
|
US20090291938A1
(en)
|
2007-11-19 |
2009-11-26 |
Takeda Pharmaceutical Company Limited |
Polo-like kinase inhibitors
|
|
EP2234986A2
(en)
|
2007-12-20 |
2010-10-06 |
Cellzome Limited |
Sulfamides as zap-70 inhibitors
|
|
EP2239264A4
(en)
*
|
2007-12-28 |
2012-01-11 |
Mitsubishi Tanabe Pharma Corp |
ANTITUMORAL MEDIUM
|
|
EP2283024B1
(en)
|
2008-03-10 |
2013-05-15 |
Janssen Pharmaceutica, N.V. |
4-aryl-2-anilino-pyrimidines as plk kinase inhibitors
|
|
US20110098288A1
(en)
|
2008-03-11 |
2011-04-28 |
Jeremy Major |
Sulfonamides as zap-70 inhibitors
|
|
FR2928923B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques
|
|
EP2112152A1
(en)
|
2008-04-22 |
2009-10-28 |
GPC Biotech AG |
Dihydropteridinones as Plk Inhibitors
|
|
WO2009153197A1
(en)
|
2008-06-18 |
2009-12-23 |
F. Hoffmann-La Roche Ag |
Halo-substituted pyrimidodiazepines as plkl inhibitors
|
|
WO2010015340A1
(en)
|
2008-08-06 |
2010-02-11 |
Bayer Schering Pharma Aktiengesellschaft |
Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
|
|
EP2334675B1
(en)
|
2008-09-16 |
2014-03-26 |
Csir |
Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
|
|
CA2741934C
(en)
|
2008-10-30 |
2016-09-13 |
Circomed Llc |
Thienotriazolodiazepine derivatives active on apo a
|
|
EP2379559B1
(en)
|
2009-01-06 |
2017-10-25 |
Dana-Farber Cancer Institute, Inc. |
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
|
|
MX2011007741A
(es)
|
2009-01-23 |
2011-09-06 |
Takeda Pharmaceutical |
Inhibidores de poli(adenosina difosfato plaquetaria (adp)-ribosa) polimerasa poli adenosina difosfato plaquetaria ribosa (parp).
|
|
CN102020643A
(zh)
|
2009-09-22 |
2011-04-20 |
上海恒瑞医药有限公司 |
二氢喋啶酮类衍生物、其制备方法及其在医药上的应用
|
|
KR20120094920A
(ko)
|
2009-09-25 |
2012-08-27 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제 억제제로서 유용한 피리미딘 유도체의 제조 방법
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
MY160456A
(en)
|
2009-11-05 |
2017-03-15 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
KR20120097508A
(ko)
*
|
2009-11-05 |
2012-09-04 |
글락소스미스클라인 엘엘씨 |
벤조디아제핀 브로모도메인 억제제
|
|
GB0919433D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
US20120329803A1
(en)
|
2010-02-17 |
2012-12-27 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones, method for production and use thereof
|
|
US8981083B2
(en)
*
|
2010-05-14 |
2015-03-17 |
Dana Farber Cancer Institute, Inc. |
Compositions and methods for treating neoplasia, inflammatory disease and other disorders
|
|
CA2799381A1
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Male contraceptive compositions and methods of use
|
|
MX373121B
(es)
|
2010-05-14 |
2020-04-30 |
Dana Farber Cancer Inst Inc |
Composiciones y metodos para el tratamiento de leucemia.
|
|
JP5913292B2
(ja)
|
2010-05-14 |
2016-04-27 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
代謝を調節する組成物および方法
|
|
JP5715241B2
(ja)
*
|
2010-05-14 |
2015-05-07 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
|
|
US9085582B2
(en)
|
2010-06-22 |
2015-07-21 |
Glaxosmithkline Llc |
Benzotriazolodiazepine compounds inhibitors of bromodomains
|
|
US20120014979A1
(en)
|
2010-07-16 |
2012-01-19 |
Alexander Dent |
Use of bcl6 inhibitors for treating autoimmune diseases
|
|
US9358233B2
(en)
|
2010-11-29 |
2016-06-07 |
Boehringer Ingelheim International Gmbh |
Method for treating acute myeloid leukemia
|
|
US9249161B2
(en)
*
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
EP2677865A4
(en)
|
2011-02-23 |
2015-04-22 |
Icahn School Med Mount Sinai |
BROMODOMAIN INHIBITORS AS MODULATORS OF GENE EXPRESSION
|
|
EP3323820B1
(en)
|
2011-02-28 |
2023-05-10 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
EP2683444A1
(en)
|
2011-03-07 |
2014-01-15 |
Fondazione Telethon |
Tfeb phosphorylation inhibitors and uses thereof
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013033270A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
|
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
DE102011082013A1
(de)
*
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
AU2013221230A1
(en)
|
2012-02-17 |
2014-10-02 |
Ansun Biopharma, Inc. |
Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients
|
|
EP2830629A4
(en)
|
2012-03-28 |
2016-01-20 |
Icahn School Of Medicine Mount Sinai |
COMPOSITIONS AND METHOD FOR THE REACTIVATION OF LATENT IMMUNE FIZIENZVIRUS
|
|
SG11201500291TA
(en)
|
2012-08-08 |
2015-04-29 |
Novomatic Ag |
Method of and system for tracking gaming activity
|
|
CA2885944A1
(en)
|
2012-09-28 |
2014-05-08 |
Oncoethix Sa |
Pharmaceutical formulation containing thienotriazolodiazepine compounds
|
|
EP2900672B1
(de)
*
|
2012-09-28 |
2017-02-22 |
Bayer Pharma Aktiengesellschaft |
Bet-proteininhibitorische 5-aryl-triazolo-azepine
|
|
WO2014071247A1
(en)
|
2012-11-02 |
2014-05-08 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
|
|
EP2935260A1
(de)
|
2012-12-20 |
2015-10-28 |
Bayer Pharma Aktiengesellschaft |
Bet-proteininhibitorische dihydropyridopyrazinone
|
|
MX2015012158A
(es)
|
2013-03-11 |
2015-12-01 |
Abbvie Inc |
Inhibidores de bomodominio tetraciclicos fusionados.
|
|
US20140254659A1
(en)
|
2013-03-11 |
2014-09-11 |
Mediatek Inc. |
Video coding method using at least evaluated visual quality and related video coding apparatus
|
|
WO2014139324A1
(en)
|
2013-03-12 |
2014-09-18 |
Abbvie Inc. |
Tetracyclic bromodomain inhibitors
|
|
HK1220916A1
(zh)
|
2013-03-14 |
2017-05-19 |
基因泰克公司 |
治疗癌症和预防癌症药物抗性的方法
|
|
US9714946B2
(en)
*
|
2013-03-14 |
2017-07-25 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
|
CA2922503C
(en)
|
2013-09-19 |
2021-10-26 |
Dana-Farber Cancer Institute, Inc. |
Methods of bh3 profiling
|
|
WO2015081280A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution
|
|
WO2015081284A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
AU2014361381A1
(en)
|
2013-12-10 |
2016-06-16 |
Abbvie Inc. |
Bromodomain inhibitors
|
|
US20160347750A1
(en)
|
2014-01-31 |
2016-12-01 |
Dana-Farber Cancer Institute, Inc. |
Dihydropteridinone derivatives and uses thereof
|
|
KR20160111036A
(ko)
|
2014-01-31 |
2016-09-23 |
다나-파버 캔서 인스티튜트 인크. |
디아제판 유도체 및 그의 용도
|
|
MX2016009974A
(es)
|
2014-01-31 |
2016-10-31 |
Dana Farber Cancer Inst Inc |
Derivados de diaminopirimidina bencensulfona y sus usos.
|
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
EP3110819A4
(en)
*
|
2014-02-26 |
2017-08-02 |
Kyorin Pharmaceutical Co., Ltd. |
Heterocyclic compounds
|
|
RU2722179C2
(ru)
*
|
2014-02-28 |
2020-05-28 |
Тэнша Терапеутикс, Инк. |
Лечение состояний, ассоциированных с гиперинсулинемией
|
|
US20180228907A1
(en)
*
|
2014-04-14 |
2018-08-16 |
Arvinas, Inc. |
Cereblon ligands and bifunctional compounds comprising the same
|
|
EP3177626A4
(en)
|
2014-08-08 |
2017-12-27 |
Dana Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
|
WO2016022970A1
(en)
|
2014-08-08 |
2016-02-11 |
Dana-Farber Cancer Institute, Inc. |
Dihydropteridinone derivatives and uses thereof
|
|
SG11201704089UA
(en)
*
|
2014-12-05 |
2017-06-29 |
H Lee Moffitt Cancer Ct & Res |
Bromodomain inhibitor as adjuvant in cancer immunotherapy
|
|
WO2016105518A1
(en)
|
2014-12-23 |
2016-06-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
US9694084B2
(en)
*
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
AU2016232705C1
(en)
|
2015-03-18 |
2021-06-17 |
Arvinas, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
US10702527B2
(en)
*
|
2015-06-12 |
2020-07-07 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
WO2017007612A1
(en)
*
|
2015-07-07 |
2017-01-12 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
CA2994969A1
(en)
*
|
2015-08-06 |
2017-02-09 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
|
|
WO2017030814A1
(en)
*
|
2015-08-19 |
2017-02-23 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
JP6886967B2
(ja)
|
2015-09-04 |
2021-06-16 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
フェノキシメチル誘導体
|
|
CA2997531A1
(en)
*
|
2015-09-09 |
2017-03-16 |
Jubilant Biosys Limited |
Tricyclic fused pyridin-2-one derivatives and their use as brd4 inhibitors
|
|
JP2018526424A
(ja)
|
2015-09-11 |
2018-09-13 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
アセトアミドチエノトリアゾロジアゼピンおよびこれらの使用
|
|
US11306105B2
(en)
*
|
2015-09-11 |
2022-04-19 |
Dana-Farber Cancer Institute, Inc. |
Cyano thienotriazolodiazepines and uses thereof
|
|
HUE046920T2
(hu)
|
2015-09-11 |
2020-03-30 |
Boehringer Ingelheim Int |
Pirazolil-szubsztituált heteroarilszármazékok és gyógyszerként történõ alkalmazásuk
|
|
US9957277B2
(en)
|
2015-11-25 |
2018-05-01 |
Effector Therapeutics, Inc. |
eIF4A-inhibiting compounds and methods related thereto
|
|
EP3380478B1
(en)
|
2015-11-25 |
2020-12-23 |
Gilead Apollo, LLC |
Ester acc inhibitors and uses thereof
|
|
CR20180336A
(es)
*
|
2015-11-25 |
2018-08-06 |
Dana Farber Cancer Inst Inc |
Inhibidores de bromodominio bivalentes y usos de los mismos
|
|
CA3005900C
(en)
|
2015-11-25 |
2023-10-31 |
Gilead Apollo, Llc |
Triazole acc inhibitors and uses thereof
|
|
MX2018006286A
(es)
|
2015-11-25 |
2018-09-07 |
Gilead Apollo Llc |
Inhibidores de acc pirazolicos y usos de los mismos.
|
|
MA43308A
(fr)
|
2015-11-25 |
2018-10-03 |
Visterra Inc |
Molécules d'anticorps se liant à april et leurs utilisations
|
|
JP2019503338A
(ja)
|
2015-11-25 |
2019-02-07 |
ギリアド アポロ， エルエルシー |
２，４−ジオキソ−１，４−ジヒドロチエノ［２，３−ｄ］ピリミジンの誘導体を含む殺真菌組成物
|
|
CA3006029C
(en)
|
2015-12-01 |
2020-08-04 |
Nihon Nohyaku Co., Ltd. |
3h-pyrrolopyridine compound, n-oxide thereof or salt thereof, agricultural and horticultural insecticide comprising the compound and method for using the same
|
|
WO2017197051A1
(en)
*
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Amine-linked c3-glutarimide degronimers for target protein degradation
|
|
WO2017197046A1
(en)
*
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
C3-carbon linked glutarimide degronimers for target protein degradation
|
|
WO2017201069A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Biotheryx, Inc. |
Oxoindoline derivatives as protein function modulators
|
|
GB201608797D0
(en)
|
2016-05-19 |
2016-07-06 |
Ucb Biopharma Sprl |
Therapeutic use
|
|
WO2018064589A1
(en)
*
|
2016-09-29 |
2018-04-05 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation using a mutant e3 ubiquitin ligase
|